Table 2.

Systemic Therapies Before Biopsy in Cohort 2

Patient characteristics	Quantity (n = 14)	Duration in months [m] resp. cycles [c] (n = 14)
ARPI	13 (93%)
Abiraterone	10 (71%)	16.5 [6.5-21] [m]
Enzalutamide	11 (79%)	6 [5-9.5] [m]
Apalutamide	0
Chemotherapy	10 (71%)
Docetaxel	10 (71%)	4.4 [3.3-5.1] [c]
Cabazitaxel	3 (20%)	4 [3-3.4] [c]

95% confidence interval is given in parenthesis, the interquartile range [Q1-Q3] in brackets. Unless otherwise stated, the data reflect the median and the interquartile range.